Home-Based Oncology Care Market - Strategic Insights and Forecasts (2026-2031)

The market is growing due to rising cancer incidence, increasing pressure on hospital oncology infrastructure, expansion of oral and subcutaneous therapies, growing telehealth adoption, and healthcare system focus on decentralized care models.

Healthcare systems are adopting home-centered oncology models to reduce hospital congestion, improve patient convenience, lower treatment costs, and maintain continuity of care during long-term cancer treatment.

Oral and subcutaneous oncology therapies reduce dependence on hospital infusion centers by enabling easier outpatient and at-home treatment administration.

Major drivers include increasing oncology patient volumes, staffing shortages in infusion centers, growth in supportive oncology care, and rising demand for outpatient-friendly therapies.

Key challenges include shortages of oncology-trained nurses, reimbursement inconsistencies, management of high-risk adverse events in home settings, and regulatory compliance requirements.